[Form 4] Lite Strategy, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Lite Strategy, Inc. (LITS) reported that a non-employee director received stock option awards. On November 14, 2025, the director was granted a stock option to purchase 55,000 shares of common stock at an exercise price of $2.02 per share, exercisable through November 14, 2035. This grant is described as a customary annual award to non-employee directors and vests 16.66666% on the grant date, with the remainder vesting monthly from December 14, 2025 through November 14, 2026.

On the same date, the director also received a separate stock option for 10,000 shares of common stock at an exercise price of $2.02 per share, also expiring on November 14, 2035. This option is described as a customary grant upon appointment to the Board, as revised on November 14, 2025, and vests in 36 equal monthly installments beginning one month after the grant date, subject to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Riezman Joshua

(Last) (First) (Middle)

C/O LITE STRATEGY, INC.

9920 PACIFIC HEIGHTS BLVD., SUITE 150

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lite Strategy, Inc. [ LITS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.02	11/14/2025		A		55,000		(1)	11/14/2035	Common Stock	55,000	(2)	55,000	D
Stock Option (Right to Buy)	$2.02	11/14/2025		A		10,000		(3)	11/14/2035	Common Stock	10,000	(2)	10,000	D

Explanation of Responses:

1. Customary annual grant to non-employee directors of options to purchase shares of common stock. Such options shall vest as follows: 16.66666% shall be vested on the date of grant, and the remaining shares subject to the option shall vest in monthly amounts beginning December 14, 2025 and continuing on the first day of each calendar month following such date and continuing through November 14, 2026.

2. Received as compensation for service on the Board.

3. Customary grant upon appointment of non-employee directors to our Board as revised on November 14, 2025, less options to purchase shares of common stock previously made to Mr. Riezman on August 8, 2025. Such options shall vest and become exercisable in 36 monthly installments, with the first installment vesting on the one-month anniversary of the date of grant, subject to continued service through the applicable vesting date.

	/s/ Justin J. File, as Attorney-in-fact for the Reporting Person	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Lite Strategy, Inc. (LITS) report in this Form 4 filing?

Lite Strategy, Inc. reported that a non-employee director received two stock option grants on November 14, 2025, covering an aggregate of 55,000 and 10,000 shares of common stock at an exercise price of $2.02 per share.

What is the exercise price and term of the Lite Strategy (LITS) director stock options?

Both stock option grants to the director have an exercise price of $2.02 per share and are exercisable until November 14, 2035, providing a long-dated right to purchase Lite Strategy common stock.

How do the 55,000 Lite Strategy (LITS) director options vest?

The 55,000-share option grant vests 16.66666% on the grant date, with the remaining shares vesting in monthly installments starting December 14, 2025 and continuing on the first day of each month through November 14, 2026, subject to continued service.

What is the vesting schedule for the additional 10,000 Lite Strategy (LITS) options?

The 10,000-share option grant vests and becomes exercisable in 36 monthly installments, with the first installment vesting on the one-month anniversary of the November 14, 2025 grant date, subject to the director’s continued service on the Board.

Why did the Lite Strategy (LITS) director receive these option grants?

The 55,000-share option is described as a customary annual grant to non-employee directors, while the 10,000-share option is described as a customary grant upon appointment to the Board, adjusted for options previously granted on August 8, 2025.

Is the reporting person a director or officer of Lite Strategy (LITS)?

The filing indicates that the reporting person serves as a Director of Lite Strategy, Inc., and the options were received as compensation for service on the Board.